Chris Crowell

Chris Crowell, PhD is Global Head of Manufacturing at Kite Pharma, a Gilead Sciences company, where he leads global manufacturing operations for cell therapy programs. He is an experienced CMC Operations Executive focused on bringing medicines through the commercialization process to positively impact patients lives. Chris joined Kite after more than two decades at Amgen, where he held senior leadership roles including Executive Director, Global Operations and Executive Director, Plant Manager Drug Substance. He holds a PhD in Pharmaceutical Sciences from University of Colorado Anschutz Medical Campus and a BS in Biological Sciences from University of California, Santa Barbara.